Skip to main content
Caplight Logo









Resilience

Resilience

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://resilience.com/

Last Round

Debt

Oct 29, 2025

Est. Valuation

$650M

Total Funding Raised

$2.68B

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Resilience is a biopharmaceutical manufacturing company that provides end-to-end manufacturing solutions for biologics, vaccines, and cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Drug Discovery, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

contract development and manufacturing organizationCDMObiomanufacturingbiologics manufacturingcell and gene therapyviral vector productionsterile manufacturingbiotech manufacturingdrug substance productionvaccine manufacturingprocess developmentpharma supply chaindigital twinsbiotech outsourcingdrug manufacturing scale-up

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Resilience Comparables

Compare Resilience with similar companies based on industry and business-model similarity.

Resilience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ElevateBio
82%
WuXi Biologics
82%
Lonza Group
80%

Resilience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtOct 29, 2025
VC RoundJun 9, 2025
GrantOct 3, 2024
Series DAug 7, 2023
DebtMar 28, 2023
Private Equity
Jan 10, 2023

Key People

Founding team and executive leadership

ramadan youseef

Co-Chief Executive Officer

Executive Team

William S. Marth

President & Chief Executive Officer

Executive Team

Andrew Montone

Chief Financial Officer

Executive Team

Resilience Investors

Notable investors and investment history

Resilience investors
InvestorRounds
Intact Private CapitalSeries C, Series D
Administration for Strategic Preparedness and ResponseGrant
GVSeries B
New Enterprise AssociatesSeries B
UL VenturesSeries B
Intact VenturesSeries C, Series D
ARCH Venture PartnersSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 17, 2026

    Monthly visitors increased 43% MoM, reaching 25.2K.

  • Apr 4, 2026

    New commercial site in Blue Ash, Ohio, for IDAP operations.

Recent news

Latest coverage and updates

  • sells_assets_toSep 21, 2026

    Resilience, Inc. sold assets to Made Scientific, Inc. on Sep 18th '26.

  • increases_headcount_bySep 14, 2026

    Resilience, Inc. will increase headcount by 400 on Jan 1st '27.

  • partners_withSep 14, 2026

    Resilience partners with Ohio Life Sciences.

  • increases_headcount_byAug 10, 2026

    Resilience, Inc. increased headcount by 200 on Jun 1st '26.

  • closes_offices_inJul 31, 2026

    Resilience, Inc. closed offices in Alachua, Florida, United States, Northern America, Americas on Jul 1st '25.

Resilience Filings

Explore SEC and related filing metadata, where available.

Resilience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersSan Diego, California
Employee Range1,306
Year Founded2020
Last FundingOct 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?